Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women.
about
Hormone therapy for sexual function in perimenopausal and postmenopausal womenSelective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practiceClinical update on the use of ospemifene in the treatment of severe symptomatic vulvar and vaginal atrophyOspemifene's effects on lipids and coagulation factors: a post hoc analysis of phase 2 and 3 clinical trial data.Pharmacology and clinical applications of selective estrogen receptor modulators.An innovative method to classify SERMs based on the dynamics of estrogen receptor transcriptional activity in living animals.From empirical to mechanism-based discovery of clinically useful Selective Estrogen Receptor Modulators (SERMs).Safety and efficacy of ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy due to menopauseEndometrial safety of ospemifene: results of the phase 2/3 clinical development program.Ospemifene use in postmenopausal women.Designing the ideal selective estrogen receptor modulator--an achievable goal?Ospemifene and 4-hydroxyospemifene effectively prevent and treat breast cancer in the MTag.Tg transgenic mouse model.Single and multiple ascending dose studies of a novel tissue-selective oestrogen receptor modulator, CHF 4227, in healthy postmenopausal women.Urogenital effects of selective estrogen receptor modulators: a systematic review.Potential of selective estrogen receptor modulators as treatments and preventives of breast cancer.Ospemifene for the treatment of dyspareunia associated with vulvar and vaginal atrophy: potential benefits in bone and breast.Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy.Pharmacologic evaluation of ospemifene.Ospemifene: first global approval.Progress and prospects in treating postmenopausal vaginal atrophy.Effects of ospemifene, a novel SERM, on biochemical markers of bone turnover in healthy postmenopausal women.Pharmacologic effects of ospemifene in rhesus macaques: a pilot study.
P2860
Q24202201-4AD7B035-173F-4E71-BA21-2C04881601D3Q25257848-98DE3C7B-C76C-4705-ACFB-E4A21405F79BQ26830744-C9B6C361-2837-4412-B854-6833502649E9Q28066699-6BA7C648-3672-4A4C-90EB-EB625EDA2BA1Q30491704-99F75BF6-4A44-4A0A-B241-22676EDDBB0EQ33384192-45C54EE3-DC32-41C9-875F-8E5AF1FF53A1Q33780223-4E4027ED-0C20-4787-A6F9-DD96BCA3BD52Q34315413-CC6173A3-4829-4BAA-96AB-4E0A7FA6D90AQ34532021-D8986F15-1CAE-4A8D-98E3-0F5769DFA17AQ34759968-328F1954-37ED-4975-87A5-81D6AFB34967Q34982860-C1EA4B2E-E3AC-4244-9C82-C35850FE00C2Q35023776-D37EEE70-DB14-46FA-942C-3A8C7C2C38A5Q35634204-213B2DAB-3343-4282-B0F9-E5BF0496ED30Q36024730-1A30162F-08F5-4754-83B9-33F1C990108AQ36359543-C6154F89-1C72-4151-8F0E-B7BC717AA1B6Q37156496-C34CB0F0-AB60-4716-8A76-C9634489625DQ37221035-8981C847-0308-4959-929C-C6DC2C67425BQ37677579-1CE6D653-53AF-4827-B0BC-778EFBD7EED3Q37739433-6CD578DE-7692-4F60-8888-D9FCA216603EQ38100714-7CB67351-1906-4A0C-9CA7-B8C1AC042A09Q39827992-D606194E-6506-4193-AA3A-64A857298C1FQ44979528-E859677B-6CBF-4798-90E9-FC803D99C219Q46530065-ECF78B3D-26A6-4A18-A899-C0DB687D54F0
P2860
Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Effects of ospemifene (FC-1271 ...... healthy postmenopausal women.
@en
Effects of ospemifene (FC-1271 ...... healthy postmenopausal women.
@nl
type
label
Effects of ospemifene (FC-1271 ...... healthy postmenopausal women.
@en
Effects of ospemifene (FC-1271 ...... healthy postmenopausal women.
@nl
prefLabel
Effects of ospemifene (FC-1271 ...... healthy postmenopausal women.
@en
Effects of ospemifene (FC-1271 ...... healthy postmenopausal women.
@nl
P2093
P1433
P1476
Effects of ospemifene (FC-1271 ...... healthy postmenopausal women.
@en
P2093
P304
P356
10.1016/S0378-5122(02)00206-2
P577
2002-11-01T00:00:00Z